Harder T - Search Results

1

Tick-borne encephalitis vaccine effectiveness and barriers to vaccination in Germany.

Nygren TM, Pilic A, Böhmer MM, Wagner-Wiening C, Wichmann O, Harder T, Hellenbrand W. Nygren TM, et al. Among authors: harder t. Sci Rep. 2022 Jul 9;12(1):11706. doi: 10.1038/s41598-022-15447-5. Sci Rep. 2022. PMID: 35810184 Free PMC article.

2

Tick-Borne Encephalitis Risk Increases with Dog Ownership, Frequent Walks, and Gardening: A Case-Control Study in Germany 2018-2020.

Nygren TM, Pilic A, Böhmer MM, Wagner-Wiening C, Wichmann O, Harder T, Hellenbrand W. Nygren TM, et al. Among authors: harder t. Microorganisms. 2022 Mar 23;10(4):690. doi: 10.3390/microorganisms10040690. Microorganisms. 2022. PMID: 35456742 Free PMC article.

3

Influenza vaccination in HIV-infected individuals: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety.

Remschmidt C, Wichmann O, Harder T. Remschmidt C, et al. Among authors: harder t. Vaccine. 2014 Sep 29;32(43):5585-92. doi: 10.1016/j.vaccine.2014.07.101. Epub 2014 Aug 12. Vaccine. 2014. PMID: 25131742 Review.

4

Influenza vaccination in patients with end-stage renal disease: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness, and safety.

Remschmidt C, Wichmann O, Harder T. Remschmidt C, et al. Among authors: harder t. BMC Med. 2014 Dec 19;12:244. doi: 10.1186/s12916-014-0244-9. BMC Med. 2014. PMID: 25523432 Free PMC article. Review.

5

Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review.

Remschmidt C, Wichmann O, Harder T. Remschmidt C, et al. Among authors: harder t. BMC Infect Dis. 2015 Oct 17;15:429. doi: 10.1186/s12879-015-1154-y. BMC Infect Dis. 2015. PMID: 26474974 Free PMC article. Review.

6

Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease.

Hellenbrand W, Koch J, Harder T, Bogdan C, Heininger U, Tenenbaum T, Terhardt M, Vogel U, Wichmann O, von Kries R. Hellenbrand W, et al. Among authors: harder t. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Nov;58(11-12):1314-43. doi: 10.1007/s00103-015-2253-z. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015. PMID: 26487381

7

Risk of Intussusception After Rotavirus Vaccination.

Koch J, Harder T, von Kries R, Wichmann O. Koch J, et al. Among authors: harder t. Dtsch Arztebl Int. 2017 Apr 14;114(15):255-262. doi: 10.3238/arztebl.2017.0255. Dtsch Arztebl Int. 2017. PMID: 28468712 Free PMC article.

8

Predicted vs observed effectiveness of outer membrane vesicle (OMV) vaccines against meningococcal serogroup B disease: Systematic review.

Harder T, Koch J, Wichmann O, Hellenbrand W. Harder T, et al. J Infect. 2017 Aug;75(2):81-94. doi: 10.1016/j.jinf.2017.05.001. Epub 2017 May 6. J Infect. 2017. PMID: 28487177 Review.

9

Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.

Harder T, Wichmann O, Klug SJ, van der Sande MAB, Wiese-Posselt M. Harder T, et al. BMC Med. 2018 Jul 18;16(1):110. doi: 10.1186/s12916-018-1098-3. BMC Med. 2018. PMID: 30016957 Free PMC article. Review.

10

Vaccination against Japanese encephalitis with IC51: systematic review on immunogenicity, duration of protection and safety.

Kling K, Harder T, Younger Z, Burchard G, Schmidt-Chanasit J, Wichmann O. Kling K, et al. Among authors: harder t. J Travel Med. 2020 Mar 13;27(2):taaa016. doi: 10.1093/jtm/taaa016. J Travel Med. 2020. PMID: 32043122

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

607 results

Search Page